A placebo-controlled, double-blind trial of the long-term effects of albuterol administration in patients with cystic fibrosis

Pediatric Pulmonology

Volumn 25, Issue 1, 1998, Pages 32-37

  König, Peter ^a   Poehler, Jill ^a   Barbero, Giulio J ^a  

^a University of Missouri   (United States)

Author keywords

Albuterol; Cystic fibrosis; Long term effect; Randomized controlled trial

Indexed keywords

PLACEBO; SALBUTAMOL;

ADOLESCENT; ARTICLE; BRONCHODILATATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; MALE; METERED DOSE INHALER; PEAK EXPIRATORY FLOW; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPIROMETRY; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADOLESCENT; ALBUTEROL; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-OVER STUDIES; CYSTIC FIBROSIS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PATIENT COMPLIANCE; SPIROMETRY; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 2642660456     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199801)25:1<32::AID-PPUL3>3.0.CO;2-Q     Document Type: Article

References (22)

1. Larsen GL, Barron RJ, Cotton EK, Brooks JG. A comparative study of inhaled atropine sulfate and isoproterenol hydrochloride in cystic fibrosis. Am Rev Respir Dis. 1979; 119:399-407.
2. Kattan M, Mansell A, Levison H, Corey M, Krastins IRB. Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis. Thorax. 1980; 35:531-535.
3. Svenonius E, Arborelins M Jr, Kautto R, Kornfält R, Lindgerg T. Lung function in cystic fibrosis. Respiration. 1980; 40:226-232.
4. Ormerod LP, Thomson RA, Anderson CM, Stableforth DE. Reversible airway obstruction in cystic fibrosis. Thorax. 1980; 35: 768-772.
5. Landau LI, Phelan PD. The variable effect of a bronchodilating agent on pulmonary function in cystic fibrosis. J Pediatr. 1973; 82:863-868.
6. Hordvik NL, König P, Morris D, Kreutz C, Barbero GJ. A longitudinal study of bronchodilator responsiveness in cystic fibrosis. Am Rev Respir Dis. 1985; 131:889-893.
7. Eggleston PA, Rosenstein BJ, Stackhouse CM, Mellits D, Baumgardner RA. A controlled trial of long-term bronchodilator therapy in cystic fibrosis. Chest. 1991; 99:1088-1092.
8. König P, Gayer D, Barbero GJ, Shaffer J. Short-term and long-term effects of albuterol aerosol therapy in cystic fibrosis: A preliminary report. Pediatr Pulmonol. 1995; 20:205-214.
9. Shwachman H, Kulczycki LL. Long-term study of 105 patients with cystic fibrosis. Am J Dis Child. 1958; 96:6-15.
10. Nickerson BG, Lemen RJ, Gerdes CB, Wegmann MJ, Robertson G. Within-subject variability and per cent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis. 1980; 122:859-860.
11. ATS: Standardization of spirometry. 1987 Update. AM Rev Respir Dis. 136:1285-1298.
12. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983; 127:725-734.
13. Wanner A. Clinical aspects of mucociliary transport. Am Rev Respir Dis. 1977;116:73-125.
14. Wood Re, Wanner A, Hirsch J, Farrell PM. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis. 1975; 111:733-738.
15. Mortensen J, Hansen A, Falk M, Nielsen IK, Groth S. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis. Chest. 1993; 103:805-811.
16. Maayan C, Bar-Yishay E, Yaacobi T, Marcus Y, Katznelson D, Yahav Y, Godfrey S. Immediate effect of various treatments on lung function in infants with cystic fibrosis. Respiration. 1989; 55:144-151.
17. Ilowite JS, Gorvoy JD, Smaldone GC. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis. 1987; 136:1445-1449.
18. Chatterjee SS, Perry AE. Salbutamol: Clinical application as pressure-paced aerosol. Postgrad Med J. 1971; 47(suppl):53-55.
19. Iravani J, Melville GN, Richter HG. Mucus production influenced by drugs: An electron microscopic study. Pneumonologie. 1976;Suppl:267-273.
20. Iravani J, Melville GN. Mucociliary function of the respiratory tract as influenced by drugs. Respiration. 1974; 31:350-357.
21. Sturgess J, Reid L. The effect of isoprenaline and pilocarpine on (a) bronchial mucus-secreting tissue and (b) pancreas, salivary glands, heart, thymus, liver and spleen. Br J Exp Pathol. 1973; 54:388-403.
22. + across the trachea of the dog in vitro. Am Rev Respir Dis. 1979; 120:547-552.